NCT02601001View on ClinicalTrials.gov

Pharmacokinetics and Safety Study of Omecamtiv Mecarbil in Healthy Japanese Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

November 13, 2015

Primary Completion Date

January 6, 2016

Study Completion Date

January 6, 2016

Conditions
Healthy Volunteer
Interventions
DRUG

Omecamtiv mecarbil

Omecamtiv mecarbil tablets for oral administration

DRUG

Placebo

Matching placebo tablets

Trial Locations (1)

890-0081

Research Site, Kagoshima

Sponsors

Lead Sponsor

Cytokinetics
All Listed Sponsors
lead

Cytokinetics

INDUSTRY

NCT02601001 - Pharmacokinetics and Safety Study of Omecamtiv Mecarbil in Healthy Japanese Adults | Biotech Hunter | Biotech Hunter